HPK vs VET โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HPK Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HighPeak Energy, Inc. Common Stock (HPK) driven by superior Growth & Margin, Momentum & Technical while VET counters with relative strength in Valuation, Options & Structure. Fundamentally, HPK trades at 24.4x Forward P/E with 18.8% operating margin (+23.0% YoY revenue) versus VET at 17.4x Forward P/E and -0.7% operating margin (+30.4% YoY). In options structure, HPK sits in BREAKDOWN (82nd %ile IV; Dealer Gamma Walls on Pro) against VET sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | HPK Revenue | VET Revenue | HPK Op. Margin | VET Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $830M | $1.86B | 15.7% | 6.7% | HPK |
| Q4 '25 | $870M | $1.85B | -7.5% | -0.8% | VET |
| Q1 '26 | $860M | $2.08B | 16.7% | 19.6% | VET |
| Q2 '26 | $1.09B | $2.25B | 30.6% | 23.9% | HPK |
| Q3 '26 | $1.03B | $2.44B | 27.9% | 25.8% | HPK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HPK | VET | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $898.4M | $1.6B | Larger Scale | VET |
| Trailing P/E Ratio Valuation | 32.7x | 17.4x | Lower Multiple | VET |
| Forward P/E Ratio Valuation | 24.4x | 17.4x | Lower Multiple | VET |
| Revenue Growth (YoY) Growth | +23.0% | +30.4% | Higher Growth | VET |
| Operating Margin (TTM) Profitability | 18.8% | -0.7% | Higher Margin | HPK |
| Net Profit Margin Profitability | -13.8% | -24.6% | Higher Margin | HPK |
| Return on Equity (ROE) Capital Efficiency | -8.1% | -20.1% | Higher ROE | HPK |
| 52-Week Range Position Momentum | 39% ($4โ$12) | 35% ($8โ$15) | Stronger Trend | HPK |
| Beta / 30D Volatility Risk Regime | -0.85ฮฒ ยท 94% Vol | -0.77ฮฒ ยท 61% Vol | Lower Realized Risk | VET |
| Unified Institutional Score Composite Signal | 72.5 / 100 (BUY) | 71.1 / 100 (BUY) | Higher Composite | HPK |